Sex Characteristics & Genital Development
At a Glance
3β-HSD deficiency changes hormone production in the adrenal glands and gonads, affecting genital development. Some 46,XY babies have atypical male genitalia, while most 46,XX babies have typical female genitalia. A specialist team should guide care and include patient input in surgery decisions.
In many forms of Congenital Adrenal Hyperplasia (CAH), patients and parents are told to expect “virilization” (masculinization). However, because 3β-HSD deficiency affects both the adrenal glands and the gonads (the testes or ovaries), the effect on genital development is often the exact opposite of what is seen in more common types [1][2]. Understanding these physical differences is a key part of navigating care.
(Note on Terminology: Throughout this guide, the terms 46,XX and 46,XY refer to an individual’s chromosomal sex determined at conception, which dictates early gonadal development. These terms describe biology, not a person’s eventual gender identity.)
Why Genital Development is Affected
The HSD3B2 gene provides instructions for an enzyme that works in both the adrenal glands and the gonads [1]. Because this enzyme is missing or weakened, the body cannot produce high-potency androgens (like testosterone) during the critical windows of fetal development [2].
Genetic Males (46,XY)
In genetic males, the testes rely on the 3β-HSD enzyme to create the testosterone needed to masculinize the external genitalia before birth [2]. When this enzyme is deficient, the male fetus is frequently undervirilized [3].
- Physical Findings: Many genetic males with 3β-HSD deficiency are born with atypical genital development (often termed ambiguous genitalia) [4]. This may include hypospadias (where the opening of the urethra is on the underside of the penis), a smaller-than-average penis, or a divided scrotum [5][6].
- Puberty: Interestingly, some boys may experience spontaneous puberty and masculinization later in life because a different version of the enzyme (type 1) in the skin can convert some precursor hormones into testosterone [3][7].
Genetic Females (46,XX)
In genetic females, the ovaries do not need to produce high levels of androgens before birth. As a result, most girls with this condition are born with typical female genitalia [4].
- Physical Findings: In one clinical cohort, only a small percentage of girls showed signs of mild virilization at birth, such as a slightly enlarged clitoris [4]. This is generally much less pronounced than the changes seen in the 21-hydroxylase form of CAH [4].
- Long-term: In adolescence and adulthood, females may experience irregular periods, acne, or hyperandrogenism resulting in PCOS-like symptoms (Polycystic Ovary Syndrome-like changes) due to the hormone imbalances [4][3].
Your Multi-Disciplinary Care Team
Because 3β-HSD deficiency affects multiple systems and is classified under Differences of Sex Development (DSD), care should involve a specialized multi-disciplinary team [8].
- Endocrinologist: Manages the life-saving hormone replacements [1].
- Urologist/Surgeon: Evaluates the anatomy and discusses options for urinary and sexual function [8].
- Geneticist: Confirms the diagnosis and provides inheritance counseling [8].
- Clinical Psychologist: Provides essential emotional support, helping patients and parents navigate complex decisions and safeguard self-esteem [9].
Navigating Decisions About Surgery
If atypical genitalia are present, questions about surgery may arise. It is important to know that medical consensus on this has shifted significantly toward individualized, cautious care [10].
- Medical Necessity vs. Deferral: Unless there is a functional emergency (such as a urinary blockage), there is rarely a medical requirement for genital surgery in infancy [10][11].
- Comprehensive Evaluation: Decisions must involve a complete anatomic and gonadal evaluation, considering long-term urinary function, sexual sensation, fertility potential, complication risks, and the possible need for surgical revisions [12][13].
- Patient Autonomy: Current guidelines emphasize the importance of involving the child in these decisions as they mature (assent/consent) [14]. Decisions made by parents should be deeply considered, with full access to psychological support and awareness of applicable laws and safeguarding standards [15][16].
Regardless of the path chosen, the overarching goal of the DSD team is to support the individual’s physical health, sensory function, and long-term psychological well-being.
Common questions in this guide
How can 3β-HSD deficiency affect genital development in 46,XY babies?
What genital findings are common in 46,XX babies with 3β-HSD deficiency?
Does a child with 3β-HSD deficiency need genital surgery in infancy?
Which specialists should care for someone with 3β-HSD deficiency and atypical genital development?
Can puberty and masculinization occur later in 46,XY people with 3β-HSD deficiency?
What should families consider before deciding on genital surgery?
Get notified when new evidence is published on Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency.
Al Alawi AM, Nordenström A, Falhammar H
Endocrine 2019; (63(3)):407-421 doi:10.1007/s12020-018-01835-3.
PMID: 30719691 - 2
Disorders of Sex Development of Adrenal Origin.
Finkielstain GP, Vieites A, Bergadá I, Rey RA
Frontiers in endocrinology 2021; (12()):770782 doi:10.3389/fendo.2021.770782.
PMID: 34987475 - 3
3β-Hydroxysteroid dehydrogenase type-2 deficiency: Our experience and gonadal function-focused systematic review.
Daga A, Phadte A, Karlekar M, et al.
Endocrine 2026; (91(1)).
PMID: 41920275 - 4
Revisiting Classical 3β-hydroxysteroid Dehydrogenase 2 Deficiency: Lessons from 31 Pediatric Cases.
Guran T, Kara C, Yildiz M, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgaa022.
PMID: 31950145 - 5
Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria.
Ladjouze A, Donaldson M, Plotton I, et al.
Frontiers in endocrinology 2022; (13()):867073 doi:10.3389/fendo.2022.867073.
PMID: 35757411 - 6
Three cases of 3β-hydroxysteroid dehydrogenase deficiency: Clinical analysis.
Chen L, Huang H, Zhang H, et al.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2021; (30(3)):289-299 doi:10.17219/acem/131220.
PMID: 33757164 - 7
Human 3β-hydroxysteroid dehydrogenase deficiency seems to affect fertility but may not harbor a tumor risk: lesson from an experiment of nature.
Burckhardt MA, Udhane SS, Marti N, et al.
European journal of endocrinology 2015; (173(5)):K1-K12 doi:10.1530/EJE-15-0599.
PMID: 26290012 - 8
Diagnostic and therapeutic pitfalls in the management of pediatric patients with 3β-hydroxysteroid dehydrogenase type 2 (3β-HSD2) deficiency - a single center experience.
Gawlik Z, Preizner-Rzucidło E, Kaleta K, et al.
Frontiers in endocrinology 2025; (16()):1642051 doi:10.3389/fendo.2025.1642051.
PMID: 41079182 - 9
Current models of care for disorders of sex development - results from an International survey of specialist centres.
Kyriakou A, Dessens A, Bryce J, et al.
Orphanet journal of rare diseases 2016; (11(1)):155 doi:10.1186/s13023-016-0534-8.
PMID: 27871307 - 10
Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how?
Mouriquand PD, Gorduza DB, Gay CL, et al.
Journal of pediatric urology 2016; (12(3)):139-49.
PMID: 27132944 - 11
Ethical issues with early genitoplasty in children with disorders of sex development.
Harris RM, Chan YM
Current opinion in endocrinology, diabetes, and obesity 2019; (26(1)):49-53 doi:10.1097/MED.0000000000000460.
PMID: 30507698 - 12
Post-operative complications following feminizing genitoplasty in moderate to severe genital atypia: Results from a multicenter, observational prospective cohort study.
Baskin A, Wisniewski AB, Aston CE, et al.
Journal of pediatric urology 2020; (16(5)):568-575 doi:10.1016/j.jpurol.2020.05.166.
PMID: 32624410 - 13
Long-Term Results of Surgical Treatment and Patient-Reported Outcomes in Congenital Adrenal Hyperplasia-A Multicenter European Registry Study.
Krege S, Falhammar H, Lax H, et al.
Journal of clinical medicine 2022; (11(15)) doi:10.3390/jcm11154629.
PMID: 35956243 - 14
Impact of the Empower-DSD training program on the health-related quality of life in children, adolescents and young adults with differences of sex development and their parents.
Neumann U, Schilling R, Wiegmann S, et al.
Frontiers in pediatrics 2026; (14()):1719768 doi:10.3389/fped.2026.1719768.
PMID: 42597469 - 15
Working towards convergence of the clinical management of differences of sex development/intersex conditions and the human rights framework: A case study.
Cools M, Verhagen E, Hoebeke P, et al.
Clinical endocrinology 2024; (101(5)):499-506 doi:10.1111/cen.15002.
PMID: 38059612 - 16
Utilization of a shared decision-making tool in a female infant with congenital adrenal hyperplasia and genital ambiguity.
Chawla R, Weidler EM, Hernandez J, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(6)):643-646 doi:10.1515/jpem-2018-0567.
PMID: 31145695
This page is for informational purposes only and does not constitute medical advice. A multidisciplinary DSD team should help you interpret anatomy, hormone needs, urinary function, and decisions about surgery.